ʻO ka lāʻau lapaʻau 1009119-65-6 Daclatasvir no ka mālama ʻana i ka maʻi maʻi hepatitis C.

ʻO ka papa lāʻau lapaʻau 1009119-65-6 Daclatasvir no ka mālama ʻana i ka maʻi Hepatitis C

ʻO ka wehewehe pōkole:

Maʻemaʻe:≧99.0%

Nā Kūlana Kūlana:E like me ka makemake

palapala hōʻoia:COA, MOA, MSDS, etc.

Kaha:50Kgs no ka mahina

Ke ola papa:ʻElua Makahiki

Noi:he mea hoʻopaneʻe o ka protein nonstructural 5A a hoʻohana ʻia no ka mālama ʻana i ka maʻi hepa C

Pōmaikaʻi Hui:ʻO ka hui kūʻai hoʻokuʻu aku ʻike me ka hoʻomaʻamaʻa ʻoihana ma ka hale hana

E hoʻouna i ka leka uila iā mākou Hoʻoiho ma ke ʻano he PDF

Huahana Huahana

FAQ

Huahana Huahana

Huahanainoa	ʻO Daclatasvir2HCl
Nā huaʻōlelo like	N,N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1 -methylethyl)-2-oxo-2,1-ethanediyl]]]ʻakika biscarbamic dimethyl ester hydrochloride;BMS 790052
CAS No.	1009119-65-6
Ka nana aku	ʻO ka pauka keʻokeʻo a ʻeleʻele melemele
ʻĀpana Molekala	C₄₀H₅₀N₈O₆.2(HCl)
Kaumaha Molekala	811.81
Hoʻohana	Papa Laʻau Laʻau no ka Noʻonoʻo
Hoʻopili	E like me kāu noi
Waihona	E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu

ʻO Daclatasvir2HCl Cas:1009119-65-6
Nā mea	Kūlana	Nā hualoaʻa
Nā hiʻohiʻona	ʻO ka pauka keʻokeʻo a ʻeleʻele melemele	Pale-melemele pauda
ʻAno wai	≦1.0%	0.25%
Maemae	≧99%	99.7%
Hoʻokahi haumia	≦0.1%	0.06%
Ke koena ma ka ʻā	≦0.1%	Hoʻokō
Ka hopena	Kūlike me ka ʻōlelo kikoʻī o loko.

ʻIkepili Hui

√ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai;
√ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi;
√ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai;
√ Keʻena hana R&D kūʻokoʻa;
√ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia;
√ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau;
√ Kiʻekiʻe Efficiency hui hana me ke ala mau.
imgsaf